Have you ever used a skincare product that seemed to work beautifully at first, only to feel, months later, as though your skin had simply stopped responding to it?
It is one of the most common beliefs in skincare: “My skin has gotten used to it.” Perhaps a retinoid no longer seems as effective, an exfoliating acid does not leave the skin quite as smooth as it once did, or a serum that once produced visible changes now appears to do very little.
The idea sounds plausible. After all, our bodies are remarkably good at adapting to repeated stimuli. In pharmacology, repeated exposure to a substance can sometimes lead to a reduced response. But does the same thing happen with everyday skincare?
The short answer is: sometimes biological adaptation can occur, but a product appearing less dramatic over time does not necessarily mean that the skin has developed tolerance to it. In many cases, what feels like “getting used to” a product may instead be a plateau in visible results, a shift in how we perceive those results, or simply the fact that the skin has already achieved much of what that product can realistically accomplish.
Understanding the difference can make it easier to decide whether you actually need to change your routine — or simply give it more time.
What Does “Skin Getting Used to a Product” Actually Mean?
The language surrounding reduced responses to repeated exposure can be confusing because terms such as tolerance, tachyphylaxis, and desensitization are sometimes used interchangeably.
In pharmacology, tachyphylaxis generally refers to a relatively rapid reduction in response following repeated exposure, often attributed to cellular depletion, although definitions vary. In contrast, tolerance involves adaptive changes within cells or tissues and tends to emerge more gradually over longer periods of repeated use.
Importantly, the kind of reduced response people usually notice with skincare does not fit the classic definition of tachyphylaxis, which typically develops quickly. So if we want to examine this experience through a pharmacological lens, the more relevant question is whether true tolerance develops with continued use of common cosmetic actives.
For a skincare product to truly become less effective because of physiological adaptation, we would need evidence that repeated exposure changes the biological response to the active ingredient in a way that meaningfully reduces its clinical effect.
So, has this actually been demonstrated?
True Physiological Adaptation in Skincare
There are clear examples in biology where repeated or prolonged exposure can lead to cellular adaptation, a process that may contribute to tolerance. Receptors can become less responsive, signaling pathways can change, and cells can alter the way they process a repeated stimulus. These are genuine physiological mechanisms through which the body can become less responsive to a substance over time.
Among skincare products, the belief that the skin can “get used to” a product is particularly common with retinoids. People often wonder whether continued use might make retinoids less effective over time. Retinoids are particularly interesting in this context because their effects involve complex signaling pathways involving retinoid receptors and retinoid-binding proteins. Research in human skin has shown that prolonged exposure to retinoic acid can regulate these pathways. At the cellular level, however, the skin’s response to retinoids is not completely static. Repeated exposure can alter the expression of retinoid receptors and binding proteins involved in retinoid signaling. These changes may modify how cells handle retinoids, but they do not necessarily switch off the downstream biological processes that retinoids activate. In fact, the effects of retinoids involve changes in gene expression and multiple cellular pathways, so adaptation at one point in the pathway does not automatically translate into a loss of the overall biological effect.
In fact, the long-term clinical evidence for topical retinoids points in the opposite direction. Studies of tretinoin have documented sustained clinical and histological improvements during prolonged use. One study followed 27 patients for up to four years and found continued histological changes associated with improved photodamaged skin, without harmful effects on keratinocytes or melanocytes.
Similarly, cosmetic retinoids such as retinol and retinaldehyde have demonstrated efficacy and tolerability with longer-term use. Reviews of cosmetic retinoids describe continued benefits for photoaged skin, including improvements in fine lines, pigmentation, and skin texture.
This does not mean that biological adaptation to retinoids is impossible. Rather, there is not strong evidence that ordinary long-term use of topical retinoids causes a clinically meaningful tolerance in which the active ingredient simply stops working.
Another easy-to-misread sign is the gradual decrease in irritation.
When people first start using a retinoid, redness, dryness, or mild peeling are common. With continued use, these reactions often become less noticeable. Early research has shown that the characteristic retinoid reaction tends to lessen over time, and long-term studies of retinaldehyde have found good tolerance even after many months of facial use.
Becoming more comfortable with a retinoid does not, by itself, indicate that its biological effects have diminished. In this case, improved tolerability and continued efficacy can coexist.
What about other popular skincare ingredients?
For many commonly used cosmetic actives — including alpha-hydroxy acids (AHAs), beta-hydroxy acids (BHAs), vitamin C, niacinamide, and peptides — there is limited evidence that an observed decline in efficacy over time represents true pharmacological tolerance or tachyphylaxis.
This does not prove that adaptation can never occur; it simply means that the evidence is not strong enough to make “my skin has become immune to it” a default explanation.
The Plateau Effect: When Improvement Naturally Slows Down
One of the simplest explanations for the feeling that a product has “stopped working” is the plateau effect.
Imagine that a product addresses a particular skin concern and produces a noticeable improvement during the first few months. As the skin gets closer to the level of improvement that the product can realistically provide, the amount of additional visible change naturally becomes smaller.
The product may still be doing exactly what it is supposed to do. The difference is that the change is now less noticeable because there is less room for dramatic improvement.
Long-term retinoid studies illustrate this concept well. Tretinoin has been shown to produce sustained improvements during prolonged treatment rather than simply losing its effect after the initial period.
AHAs provide another useful example. Clinical studies have found improvements in properties such as skin hydration, texture, and the appearance of lines and wrinkles with continued use of glycolic and lactic acids.
If the first few weeks of an exfoliating product transform rough, dull skin into noticeably smoother skin, the difference between month one and month six is unlikely to look equally dramatic. That does not necessarily mean the ingredient has become less active. It may simply mean that the most obvious initial change has already occurred.
When Your Skincare “Feels” Less Effective
Perception also plays an important role.
When we first start a new product, we tend to pay close attention to our skin. We look in the mirror more often, take before-and-after photos, notice every small improvement, and may even experience the novelty of a new texture or finish.
Over time, those changes become part of our normal appearance. This can create a kind of perceptual contrast: the difference between before and now feels smaller simply because “now” has become familiar.
Think about how dramatically a new haircut can feel on the first day. A few weeks later, the same haircut may seem completely ordinary — not because your hair has somehow reverted, but because your brain has adjusted to seeing it. Skincare can work similarly.
There can also be changes in the skin that have nothing to do with the product itself. Seasonal weather, humidity, sun exposure, hormonal shifts, stress, sleep, cleansing habits, and the introduction of other products can all affect how the skin looks and feels.
For example, a moisturizer may appear less impressive during a dry winter than it did during a humid summer. An exfoliant may seem less effective when the underlying problem has changed. A retinoid may appear to have “stopped working” when the original concern has improved but a different concern has become more noticeable.
So before concluding that the skin has adapted, it is worth asking a simpler question: Has the product actually become less effective, or has the context changed?
Should You Change a Product That Seems to Have Stopped Working?
Not necessarily.
If a product is well tolerated and continues to address the concern for which it was chosen, there is usually no scientific reason to change it simply because the dramatic early results have become less obvious.
Before deciding to switch products, it can help to pause and ask a few practical questions:
- What specific result were you hoping for?
- Have you given the product enough consistent time?
- Has the main concern you were treating actually changed?
- Has anything else in your routine or environment shifted?
- And finally — is the product still well tolerated and appropriate for what your skin needs now?
Changing a product makes sense when it is irritating, no longer matches your current concern, has degraded because of poor storage, or simply does not have enough evidence for the result you want. Changing it only because the dramatic early results have become less obvious is usually not necessary.
For some actives, especially retinoids, long-term use is not inherently a reason to stop. Clinical evidence shows that benefits can persist with continued use, while tolerability may improve over time.
The Bottom Line
The idea that skin simply gets used to skincare products is appealing because it offers a simple explanation for a common experience. But that feeling can come from several different things: a natural plateau in visible results, a shift in how we notice changes, environmental or lifestyle factors, or — less often — true physiological adaptation.
For most commonly used cosmetic actives, evidence of clinically meaningful tolerance is limited. A product doesn't need to deliver dramatic new results every few weeks to work. Often its real success is quieter: maintaining the improvements already achieved and supporting the skin consistently over time.
Instead of changing products the moment results feel less exciting, it is more useful to ask what the evidence supports, what outcome you are actually targeting, and whether your current routine still matches that goal.
References
- Svensson CK. Attenuation of Response to Repeated Drug Administration: A Proposal for Differentiating Tachyphylaxis and Tolerance. J Pharmacol Exp Ther. 2022;381(1):22–32.
- Elder JT, Åström A, Pettersson U, Tavakkol A, Griffiths CE, Krust A, et al. Differential regulation of retinoic acid receptors and binding proteins in human skin. J Invest Dermatol. 1992;98(5):673–679.
- Farris P. Retinol: The Ideal Retinoid for Cosmetic Solutions. J Drugs Dermatol. 2022;21(7 Suppl):s4–s10.
- Mambwe B, et al. Cosmetic retinoid use in photoaged skin: A review of the compounds, their use and mechanisms of action. Int J Cosmet Sci. 2025;47(1):45–57.
- Bhawan J, Olsen E, Lufrano L, Thorne EG, Schwab B, Gilchrest BA. Histologic evaluation of the long term effects of tretinoin on photodamaged skin. J Dermatol Sci. 1996;11(3):177–182.
- Sitohang IBS, Makes WI, Sandora N, Suryanegara J. Topical tretinoin for treating photoaging: A systematic review of randomized controlled trials. Int J Womens Dermatol. 2022 Mar 25;8(1):e003.
- Sachsenberg-Studer EM. Tolerance of topical retinaldehyde in humans. Dermatology. 1999;199 Suppl 1:61–63.
- Fluhr JW, Vienne MP, Lauze C, Dupuy P, Gehring W, Gloor M. Tolerance profile of retinol, retinaldehyde and retinoic acid under maximized and long-term clinical conditions. Dermatology. 1999;199 Suppl 1:57–60.
- Bernstein EF, et al. Topical 8% glycolic acid and 8% L-lactic acid creams for the treatment of photodamaged skin. Arch Dermatol. 1997;133(11):1400–1404.
- Van Scott EJ, Yu RJ. Control of keratinization with alpha-hydroxy acids and related compounds. Arch Dermatol. 1974;110(4):586–590.
